Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly womenShow others and affiliations
2022 (English)In: Infectious Agents and Cancer, E-ISSN 1750-9378, Vol. 17, no 1, article id 42Article in journal (Refereed) Published
Abstract [en]
PURPOSE: Cervical cancer prevention for older women can be challenging since there are no specific guidelines for this group. This study aimed to determine the incidence of oncogenic HPV and HPV-related dysplasia in elderly women 5 years after being HPV negative.
METHODS: Invited women participated five years earlier in a study where self-sampling for HPV testing was applied, at this time, they were all HPV negative. The women were now, five years later invited to perform self-sampling for HPV testing. Women with a positive result performed a repeat HPV test. Those with a positive repeat HPV test were examined by colposcopy, biopsy and cytology.
RESULTS: Of the 804 invited women, 634 (76.9%) agreed to participate in the study and a self-sampling kit was sent to them. Of these, 99.6% (632/634) sent a sample to the HPV laboratory. The participation rate in each age group was 93.3% at age 65, 74.0% at age 70, 80.7% at age 75 and 64.6% at age 80. Overall 18 women (2.8%, 95% CI 3.2 to 6.0) were HPV positive in the first test and 8 (1.3%, 95% CI 0.6 to 2.6) in the second test. Sampling for the second test was done on average 5.4 months after the first test. Fifty per cent (4/8) of the women with a positive repeat test had dysplasia in histology.
CONCLUSION: The incidence of HPV in previously HPV-negative elderly women was low. Among women who were HPV positive in a repeat test, there was a high prevalence of low grade dysplasia.
Place, publisher, year, edition, pages
BioMed Central (BMC), 2022. Vol. 17, no 1, article id 42
Keywords [en]
Cervical intraepithelial neoplasia, Cervix, Elderly, HPV, Self-sampling
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-100634DOI: 10.1186/s13027-022-00453-zISI: 000835677600002PubMedID: 35922825Scopus ID: 2-s2.0-85135366119OAI: oai:DiVA.org:oru-100634DiVA, id: diva2:1688687
Funder
Uppsala UniversityInsamlingsstiftelsen Lions Cancerforskningsfond Mellansverige Uppsala-Örebro, 56131
Note
Funding Agency:
Regional Research Council Uppsala-Örebro
2022-08-192022-08-192024-03-14Bibliographically approved